Praful Patel, MD
Obstetrics & Gynecology · Dothan, ALNPI 1821020074
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $52,273 of the $64,887 with a category attached, or 80.6%. Astellas Pharma US Inc accounts for 89.1% of it on its own, with 29 other manufacturers making up the rest. Among obstetrics & gynecology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 246 payments — averaging $263.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$58K
- Intuitive Surgical$4K
- AbbVie$886
- Hologic Sales And Service, LLC$639
- Coloplast$438
- Mayne Pharma Commercial LLC$259
- plus $1K from 24 others
Across 2 payments — averaging $8102.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$16K
What the payments were for
- Speaking & faculty fees$52,27381%
- Travel & lodging$5,9559%
- Food & beverage$5,5259%
- Education$1,1202%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 73 | $57,829 |
| Intuitive Surgical | 10 | $3,544 |
| AbbVie | 42 | $886 |
| Hologic Sales And Service, LLC | 24 | $639 |
| Coloplast | 9 | $438 |
| Mayne Pharma Commercial LLC | 8 | $259 |
| Pfizer | 16 | $223 |
| Sumitomo Pharma America, Inc. | 10 | $213 |
| Bayer | 9 | $131 |
| Exeltis, USA Inc. | 6 | $122 |
| Therapeuticsmd, Inc. | 5 | $75 |
| Amgen | 5 | $72 |
| Millicent US Inc | 4 | $59 |
| Urovant Sciences Inc | 3 | $57 |
| Scynexis, Inc. | 3 | $41 |
| Myovant Sciences Inc. | 3 | $36 |
| Organon | 2 | $29 |
| Coopersurgical, Inc. | 2 | $25 |
| Solventum Corporation | 1 | $25 |
| Conmed Corporation | 1 | $22 |
| Davol Inc. | 1 | $22 |
| Radius Health, Inc. | 1 | $20 |
| AstraZeneca | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Merck | 1 | $16 |
| Shield Therapeutics Inc | 1 | $16 |
| Duchesnay USA Incorporated | 1 | $15 |
| Medtronic | 1 | $14 |
| Avion Pharmaceuticals | 1 | $14 |
| Agile Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$56,654
- Da Vinci Surgical System$2,500
- DAVINCI XI$1,000
- ALTIS$316
- Myosure$125
- NovaSure$125
- Orilissa$125
How this compares
$64,887 in reported general payments places this provider in the 95th percentile of 537 obstetrics & gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 58 | $30,316 |
| MyrbetriqMirabegron | 40 | $18,520 |
| PremarinEstrogens, Conjugated | 34 | $9,935 |
| Estradiol | 123 | $5,584 |
| OsphenaOspemifene | 11 | $2,554 |
| Estradiol (Twice Weekly)Estradiol | 22 | $1,992 |
| ValacyclovirValacyclovir Hcl | 20 | $759 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 29 | $690 |
| Solifenacin Succinate | 26 | $602 |
| Clobetasol Propionate | 15 | $558 |
| DottiEstradiol | 12 | $405 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 32 | $172 |
| Fluconazole | 25 | $166 |
| Norethindrone Acetate | 16 | $69 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $68 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $213 | $30,31658 claims |
| Astellas Pharma US IncMyrbetriq | $57,829 | $18,52040 claims |
| PfizerPremarin | $223 | $9,93534 claims |
| Duchesnay USA IncorporatedOsphena | $15 | $2,55411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 537 obstetrics & gynecology providers in Alabama.
Other obstetrics & gynecology in Dothan
- Theodore TsaltasBirmingham$853K
- Richard BrownGulf Shores$429K
- Timothy HughesMobile$149K
- Allison CalhounMobile$132K
- Angela McCool-PearsonFairhope$57K
- Tomeka RobertsBirmingham$44K
- Percy HudsonBirmingham$29K
- Heidi StraughnBirmingham$29K
- Francois BlaudeauHomewood$25K
- Melinda FrameMobile$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.